Why Avita Medical, GenusPlus, Mesoblast, and Polynovo shares are storming higher

These shares are having a better day than most today. But why?

| More on:
a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a volatile session but is currently on course to record a small gain. In early afternoon trade, the benchmark index is up slightly to 8,208.5 points.

Four ASX shares that are rising more than most today are listed below. Here's why they are climbing:

AVITA Medical Inc (ASX: AVH)

The AVITA Medical share price is up 5% to $4.00. Investors have been buying this regenerative medicine company's shares after the United States Food and Drug Administration (FDA) approved its premarket approval (PMA) supplement for RECELL GO mini. AVITA CEO, Jim Corbett, said: "The FDA approval of RECELL GO mini strengthens our ability to provide clinicians with fit-for-purpose solutions that meet the diverse needs of patients with full-thickness wounds. By introducing a treatment option specifically for smaller wounds, we are expanding the accessibility of RECELL to a wider range of patients."

GenusPlus Group Ltd (ASX: GNP)

The GenusPlus Group share price is up 4% to $2.55. This follows news that the essential services provider has won another big contract. According to the release, GenusPlus has been awarded a contract for Stage 1 of TasNetworks' North West Transmission Developments (NWTD) project. The company notes that the staged contract commences with the award of the early contractor involvement phase of NWTD Stage 1 which is worth approximately $42 million to GenusPlus.

Mesoblast Ltd (ASX: MSB)

The Mesoblast share price is up 1.5% to $2.57. This biotechnology company's shares have been on fire this week after announcing some big news. Mesoblast revealed that the US FDA has approved its Ryoncil (remestemcel-L) product as the first mesenchymal stromal cell (MSC) therapy in the United States. It notes that Ryoncil is the only MSC therapy approved in the U.S. for any indication. It is also the only approved therapy for steroid-refractory acute graft versus host disease (SR-aGvHD) in children 2 months and older, including adolescents and teenagers.

Polynovo Ltd (ASX: PNV)

The Polynovo share price is up a further 1.5% to $2.09. This medical device company's shares have been pushing higher this week after it released a trading update. That trading update revealed that the company achieved its first $10 million sales month in November. This means that year to date, Polynovo's revenue is now $49.6 million. This is an increase of $10.1 million or 25.4% on the prior corresponding period.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Avita Medical, GenusPlus Group, and PolyNovo. The Motley Fool Australia has recommended Avita Medical and PolyNovo. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why EOS, News Corp, Polynovo, and Pro Medicus shares are roaring higher today

These shares are starting the week positively. But why?

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

5 ASX 200 stocks marching higher this week even as the market sinks

These five ASX 200 companies are shrugging off the broader selling to march higher this week.

Read more »

Rising share price chart.
Share Gainers

Why Novonix, HMC, Karoon Energy, and Ventia shares are pushing higher

These shares are ending the week on a positive note. But why?

Read more »

A young woman smiles as she rides a zip line high above the trees.
Share Gainers

3 top ASX 200 stocks I wish I'd owned in 2024

These three top ASX 200 stocks are racing higher in 2024.

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Champion Iron, EBR Systems, Mesoblast, and Patriot Battery Metals shares are surging today

These shares are avoiding the market selloff on Thursday. But why?

Read more »

A man looking at his laptop and thinking.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended up snatching defeat from the jaws of victory today.

Read more »

Excited group of friends sitting on sofa watching sports on TV and celebrating.
Share Gainers

Why Clarity, Omni Bridgeway, Santana Minerals, and Vulcan shares are pushing higher today

These shares are having a good time on hump day. But why?

Read more »

Man with rocket wings which have flames coming out of them.
Share Gainers

Guess which ASX All Ords stock just rocketed 44%

Investors are sending the ASX All Ords stock racing higher today. But why?

Read more »